Filing Details

Accession Number:
0001209191-19-023147
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-03 16:33:45
Reporting Period:
2019-04-01
Accepted Time:
2019-04-03 16:33:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827871 Eagle Pharmaceuticals Inc. EGRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1469124 Scott Tarriff C/O Eagle Pharmaceuticals, Inc.
50 Tice Blvd., Suite 315
Woodcliff Lake NJ 07677
Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Commn Stock Disposition 2019-04-01 24,975 $50.15 1,500,202 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $51.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.